Company news & financial analysisCompany reporting, clearly explained.
TICKERBYLINE.

Beyond the headline.
Inside the numbers.

Ticker Byline

Molson Coors Beverage Company

Molson Coors news and analysis covering beer demand, earnings, cash flow, debt, portfolio changes and management forecasts.

Ticker
TAP
Exchange
XNYS
SEC CIK
0000024545

Molson Coors Beverage Company brews and sells beer, including Coors Light, Miller Lite, Coors Banquet and Molson Canadian. It is also expanding into ready-to-drink cocktails and non-alcoholic drinks. It reports Americas and EMEA&APAC segments. Class B shares trade as TAP on the New York Stock Exchange; Class A shares trade as TAP.A.

Comparable quarterly results

Millions of U.S. dollars except EPS. Three months ended September 30. Net sales exclude excise taxes.
MeasureQ3 2025Q3 2026
Net sales$2,973.5$2,926.5
Gross profit, GAAP$1,173.5$1,030.4
Marketing, general and administrative expenses, GAAP$686.7$633.5
Net income attributable to Molson Coors, GAAP-$2,927.6$271.5
Diluted EPS, GAAP-$14.79$1.45
Underlying pretax profit$426.0$349.0
Underlying diluted EPS$1.67$1.46

The prior-year GAAP loss included $3,645.7 million of goodwill impairment and $273.9 million of other intangible write-downs. Underlying profit removes those items and specified restructuring, investment and derivative adjustments. Underlying pretax profit fell 18.1% as reported, or 17.4% after removing currency movements.

U.S. financial volume fell 2.2%, aided by shipment timing, while brand volume fell 5.6%. The company expects those trends to converge in Q4. Outside the Americas, underlying pretax profit rose 5.5% at constant currency despite lower volumes, supported by lower marketing and administrative expenses.

Earlier expectations and the November reset

In August, Molson Coors reaffirmed annual sales growth of minus 1% to plus 1%, underlying pretax profit down 15% to 18%, and underlying EPS down 11% to 15%. Sales and pretax comparisons remove currency movements.

The November forecast calls for sales to fall 1% to 2%, underlying pretax profit to fall 21% to 24%, and underlying EPS to fall 16% to 19%. Underlying free cash flow is now expected at $1.0 billion, plus or minus 10%, compared with $1.1 billion on the same tolerance before. Annual capital expenditure guidance remains $650 million incurred, plus or minus 5%; incurred spending differs from cash paid.

Cash generation and capital allocation

Millions of U.S. dollars. Nine months ended September 30. Underlying free cash flow adds specified cash adjustments to operating cash less cash capital spending.
Measure20252026
Operating cash flow$1,243.7$1,280.4
Cash additions to property, plant and equipment$533.7$469.0
Operating cash less cash capital spending$710.0$811.4
Specified cash addbacks$72.1$40.6
Underlying free cash flow$782.1$852.0

Current operating cash includes a $107.5 million settlement of interest-rate swaps. Payment timing, lower incentive payouts and the absence of a prior litigation payment also helped cash. Dividends used $273.1 million and cash share repurchases used $254.9 million during the first nine months.

Debt and available liquidity

At September 30, cash was $602.2 million and debt carrying value was $5,995.8 million, including finance leases. Net debt was $5,393.6 million, compared with $5,341.8 million a year earlier. Net debt to underlying EBITDA rose to 2.53 times from 2.28 times. That is a different calculation from the credit agreement's covenant ratio.

The $2 billion revolving facility matures June 26, 2030. About $1.7 billion remained available after backing commercial paper. Molson Coors was in compliance with its debt covenants at September 30. During 2026 it repaid $2 billion of U.S. notes at their July maturity and Canadian-dollar notes, and issued replacement U.S.-dollar and Canadian-dollar debt.

Completed portfolio changes and the next valuation test

Molson Coors acquired Atomic Brands, the maker of Monaco Cocktails, on April 1, 2026 for approximately $275 million in cash. The purchase expands its ready-to-drink cocktail business. Preliminary allocation included approximately $65 million for the brand and about $200 million of goodwill.

Its Fever-Tree expansion combines exclusive U.S. production, marketing and sales rights, the earlier acquisition of the U.S. entity and a minority investment in listed Fevertree Drinks. It has not bought the entire listed group.

Reduced forecast cash flows led to a quantitative Americas goodwill assessment as of October 1, 2026. It was still in progress when the report was filed. Any resulting charge would be recorded in Q4. The key operating tests are whether U.S. brand volumes stabilize and whether cost savings can absorb ongoing production and logistics inflation.

Latest reporting